Vapreotide
|
Systematic (IUPAC) name |
---|
2-Amino-N-[10-(4-aminobutyl)-4-{[1-carbamoyl-2-(1H-indol-2-yl)ethyl]carbamoyl}-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl]-3-phenylpropanamide |
Clinical data |
---|
Trade names |
Sanvar |
---|
Pharmacokinetic data |
---|
Half-life |
30 minutes |
---|
Identifiers |
---|
|
103222-11-3 |
---|
|
H01CB04 |
---|
PubChem |
CID 23725064 |
---|
DrugBank |
DB04894 |
---|
ChemSpider |
64425 |
---|
UNII |
2PK59M9GFF |
---|
KEGG |
D06281 |
---|
Synonyms |
Octastatin |
---|
Chemical data |
---|
Formula |
C57H70N12O9S2 |
---|
|
1131.37 g/mol |
---|
SMILES
- C(C)C1NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=C2C=CC=C3)NC(=O)C(CC2=CC=C(O)C=C2)NC(=O)C(CSSCC(NC1=O)C(=O)NC(CC1=CC2=C(N1)C=CC=C2)C(N)=O)NC(=O)C(N)CC1=CC=CC=C1
|
Physical data |
---|
Density |
1.4 g/cm3 |
---|
Boiling point |
1,540.9 °C (2,805.6 °F) |
---|
Vapreotide (Sanvar) is a synthetic somatostatin analog. It is used in the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and AIDS-related diarrhea.[1]
References
- ↑ DrugBank DB04894
|
---|
| Hypothalamic | |
---|
| Anterior pituitary | |
---|
| Posterior pituitary | |
---|
| |
---|
| Description |
- Glands
- Hormones
- thyroid
- mineralocorticoids
- Physiology
- Development
|
---|
| Disease |
- Diabetes
- Congenital
- Neoplasms and cancer
- Other
- Symptoms and signs
|
---|
| Treatment |
- Procedures
- Drugs
- calcium balance
- corticosteroids
- oral hypoglycemics
- pituitary and hypothalamic
- thyroid
|
---|
|
|